Skip to content
DefDex

Federal award

ABZYME THERAPEUTICS LLC

W911QY16P0050

ContractSBIR/STTR SR1

Obligated and Ceiling

Obligated (net)
$99,987.61
Ceiling (potential value, not spending)
$149,964.61
Current value
$99,987.61
Gross positive obligations
$99,987.61

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ABZYME THERAPEUTICS LLC · H2MLEFWV36N6
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ABZYME THERAPEUTICS LLC · H2MLEFWV36N6
Awarding agency
Department of War · sub-agency 2100 · office W911QY
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Industry (NAICS)
541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
PIID
W911QY16P0050
Award type code
B
Actions
5 · Dec 23, 2015 to Jun 7, 2016
Why it is listed
SBIR/STTR award

Open this award on USAspending →

Action History5

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 7, 2016FY2016P00004M$0.00
—
Mar 17, 2016FY2016P00003M$0.00
—
Jan 12, 2016FY2016P00002M$0.00
—
Jan 11, 2016FY2016P00001M$0.00
—
Dec 23, 2015FY20160—$99,987.61
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.